Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
Key Figures
0.081 Open
0.100 High
14.09K Volume
-- P/E TTM
-- P/E Dynamic
-- Dividend TTM
-- Turnover Ratio
0.081 Prev. Close
0.081 Low
1.18K Turnover
-- P/E Static
-- P/B
0.00% Div Yield TTM
-- ROA
0.170 52wk High
0.89 Volume Ratio
-- Net Profit
-- Shares
-- EPS TTM
-- Beta
-- ROE
0.060 52wk Low
23.76% Amplitude
-- Gross Margin
0.00 Market Cap
0.12 Reward/Risk
8.07% Risk Rate
TradingKey Stock Score No stock score available due to insufficient data.
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 News
View more
More news coming soon, stay tuned...
Financial Indicators EPS Relevant data have not been disclosed by the company yet.
Total revenue Relevant data have not been disclosed by the company yet.
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 Info Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Ticker Symbol DMIIR
Company Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
CEO Stockwell (Lynn)
Website
FAQs
What is the current price of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR)? The current price of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) is 0.08.
What is the symbol of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030? The ticker symbol of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 is DMIIR.
What is the 52-week high of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030? The 52-week high of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 is 0.17.
What is the 52-week low of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030? The 52-week low of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 is 0.06.
What is the market capitalization of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030? The market capitalization of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 is 642.73M.